P366: BLINATUMOMAB ADDED TO PREPHASE AND CONSOLIDATION THERAPY IN NEWLY DIAGNOSED PRECURSOR B-ALL IN ADULTS. A PHASE II HOVON TRIAL

• A. Rijneveld,
• P. Gradowska,
• M. Bellido,
• O. de Weerdt,
• A. Gadisseur,
• D. Deeren,
• L. van der Wagen,
• Y. Jauw,
• R. Fijnheer,
• D. van Lammerren,
• D. Selleslag,
• S. Halkes,
• B. Biemond,
• D. Breems,
• I. Moors,
• G. van Sluis,
• M. Bakkus,
• C. Homburg,
• V. Janda,
• V. van der Velden,
• J. Cornelissen

Affiliations

A. Rijneveld

1 Hematology

P. Gradowska

2 HOVON data Center, Erasmus MC, Rotterdam

M. Bellido

3 hematology, Univerisity Medical Center Groningen, Groningen

O. de Weerdt

4 Hematology, Sint Antonius Hospital, Nieuwegein, Netherlands

A. Gadisseur

5 Hematology, Universitair ziekenhuis Antwerpen (UZA), Antwerp

D. Deeren

6 Hematology, AZ Delta, Roeselare, Belgium

L. van der Wagen

7 Hematology, University Medical Center, Utrecht

Y. Jauw

8 Hematology, Amsterdam UMC, VU University Medical Center, Amsterdam

R. Fijnheer

9 Hematology, Meander Medical Center, Amersfoort

D. van Lammerren

10 Hematology, Haga Teaching Hospital, The Hague, Netherlands

D. Selleslag

11 Hematology, St Jan hospital, Brugge, Belgium

S. Halkes

12 Hematology, Leiden University Medical Center, Leiden

B. Biemond

13 Hematology, Amsterdam UMC, Amsterdam Medical Center, Amsterdam, Netherlands

D. Breems

14 Hematology, ZNA Stuivenberg, Antwerpen

I. Moors

15 Hematology, Universiteits ziekenhuis Gent, Gent, Belgium

G. van Sluis

16 Hematology, Isala Clinic, Zwolle, Netherlands

M. Bakkus

17 Hematology, University Hospital Brussels, Brussels, Belgium

C. Homburg

18 Immunocytology, Sanquin Diagnostic Services, Amsterdam, Netherlands

V. Janda

19 Immunology, UZ Gent, Gent, Belgium

V. van der Velden

20 Immunology

J. Cornelissen

21 Hematology, Erasmusm University Medical Center, Rotterdam, Netherlands